Subcellular pharmacokinetics and its potential for library focusing

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Computational Chemistry
• Toxicology

Background:

• Subcellular pharmacokinetics (SP) is crucial for optimizing compound libraries in high throughput screening.
• Traditional methods often struggle with complex biological systems and human ADMET prediction.
• Understanding drug disposition kinetics as a non-linear function of structure is key.

Purpose of the Study:

• To demonstrate the capability of SP in optimizing drug design for improved ADMET properties.
• To compare the predictive power of SP models against empirical models.
• To validate SP models using a quantitative structure-activity relationship of phenolic compound toxicity.

Main Methods:

• Defining narrow ranges of physicochemical properties (lipophilicity, acidity, etc.) for compound libraries.
• Developing conceptual SP models incorporating membrane transport, protein binding, and cellular reactions.
• Utilizing a model-based quantitative structure-activity relationship (QSAR) for toxicity prediction.
• Employing leave-extremes-out cross-validation for model performance assessment.

Main Results:

• SP models demonstrated superior predictive ability compared to empirical models, especially outside the training parameter space.
• SP models showed robustness, with minimal changes when parameter spaces were reduced.
• Empirical models exhibited significant variability depending on the training data subset.
• The study successfully modeled phenolic compound toxicity against Tetrahymena pyriformis based on lipophilicity and acidity.

Conclusions:

• SP provides a more accurate and reliable method for tailoring drug properties to ensure optimal ADMET.
• SP models offer a detailed framework for drug property optimization, outperforming traditional QSAR and drug-likeness assessments.
• The SP approach enhances the precision of predicting and mitigating potential drug toxicity and permeability issues.